hg_142273.1

Basic information about the TSS

---

TSS ID: hg_142273.1 Species: human Chr: chr14		Start: 22957072 End: 22957097 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000541587.6 ENST00000490506.5 ENST00000553794.5 ENST00000554651.5 ENST00000554406.1 BC002554 BX247995 AK057779 AK026016 Distance: 0 GeneID: 54930 HGNC/MGI_ID: HGNC:20163 UniProt_ID: G3V2I5 Q9H6D7

Gene_name: HAUS augmin like complex subunit 4 Gene_symbol: HAUS4 Gene_synonyms: FLJ20424 Gene_source: HGNC:20163

TATA-Box annotation

---

Distance to TSS:	5
Nearest PromoterID:	NM_017815
Entrez ID:	54930
Nearest Unigene:	Hs.442782
Nearest Refseq:	NM_017815
Nearest Ensembl:	ENSG00000092036
Gene Name:	HAUS augmin like complex subunit 4
Gene Alias:	C14orf94
Gene Description:	HAUS augmin like complex subunit 4
Gene Type:	protein-coding
CpG%:	0.11
GC%:	0.721393
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@HAUS4 p2@HAUS4 p3@HAUS4 p4@HAUS4
Sample		p1@HAUS4	p2@HAUS4	p3@HAUS4	p4@HAUS4
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	10.71	4.09	1.75	1.75
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	10.93	4.65	1.21	2.83
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	7.72	5.02	1.93	2.51
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	11.64	2.91	0.62	1.04
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	11.70	4.50	1.35	2.70
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	8.53	3.10	1.36	0.97
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	7.84	5.45	1.96	1.74
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	8.72	4.36	1.45	2.18
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	8.98	1.92	2.14	1.50
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	12.17	7.54	2.32	4.06
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	11.72	8.08	2.83	3.23
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	11.38	4.07	1.22	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	16.76	8.54	2.58	1.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	14.88	6.62	1.20	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	16.47	6.37	1.32	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	20.12	5.53	2.26	1.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	14.20	5.24	1.97	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	16.45	4.64	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	13.33	8.00	3.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	16.10	6.17	1.81	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	14.17	6.28	2.00	2.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	13.98	5.87	1.73	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	15.38	5.95	1.68	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	17.47	5.10	1.70	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	17.29	5.93	1.81	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	18.04	7.28	1.90	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	17.03	8.24	1.65	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	16.74	5.42	0.94	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	12.76	5.65	2.58	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	13.75	5.07	1.45	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	15.70	4.61	2.09	1.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	15.44	3.91	2.93	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	13.93	5.28	2.74	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	11.88	3.96	2.31	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	16.83	4.49	1.50	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	17.25	4.02	1.92	1.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	12.47	4.50	1.84	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	13.70	3.63	1.81	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	16.48	4.32	1.35	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	15.60	4.32	2.88	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	13.88	5.18	1.18	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	11.71	5.42	1.90	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	13.92	2.95	1.05	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	15.21	5.42	1.75	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	11.85	4.82	1.81	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	13.96	5.82	1.16	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	13.91	3.60	1.44	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	13.41	3.87	1.19	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	13.17	3.83	1.91	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	12.54	4.25	0.61	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	15.17	4.30	1.23	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	13.79	3.11	2.00	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	15.61	1.06	1.77	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	10.27	1.66	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	4.19	3.36	0.00	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	5.51	1.38	2.30	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	11.34	1.94	0.00	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	11.88	2.57	0.96	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	8.49	2.51	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	7.05	0.71	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	11.78	2.80	0.56	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	3.18	2.39	2.39	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	8.15	1.36	1.02	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	10.72	2.60	0.97	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	17.39	2.13	1.06	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	11.70	2.44	0.98	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	12.40	2.98	0.99	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	10.79	2.35	0.94	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	9.94	5.63	2.98	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	15.78	4.02	2.47	1.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	15.29	4.59	2.75	1.83
Adipocyte - breast, donor1	11376-118A8	6.49	2.85	1.43	1.27
Adipocyte - breast, donor2	11327-117E4	4.33	1.60	0.48	0.48
Adipocyte - omental, donor1	11473-119C6	4.20	1.40	1.27	0.89
Adipocyte - omental, donor2	11474-119C7	5.98	2.99	2.99	2.99
Adipocyte - omental, donor3	11475-119C8	8.04	0.67	0.67	0.67
Adipocyte - perirenal, donor1	11476-119C9	5.10	2.55	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	7.70	4.40	2.20	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	1.35	0.90	1.35	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	11.12	4.17	1.04	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	5.28	1.37	1.17	1.37
Adipocyte differentiation, day04, donor2	13022-139D7	6.18	1.29	1.03	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	5.85	1.39	1.39	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	6.47	2.35	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	4.34	2.09	1.37	1.05
Adipocyte differentiation, day08, donor2	13023-139D8	5.49	2.26	0.97	0.97
Adipocyte differentiation, day08, donor3	13026-139E2	6.40	1.07	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	6.12	3.34	1.67	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	3.74	3.33	1.25	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	4.77	3.27	1.51	1.26
Adipocyte differentiation, day12, donor3	13027-139E3	4.25	0.98	0.65	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	3.65	1.83	0.30	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	1.77	4.64	1.77	1.33
Alveolar Epithelial Cells, donor2	11590-120G6	8.61	4.30	3.23	3.94
Alveolar Epithelial Cells, donor3	11671-122G6	5.99	8.39	1.20	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	9.89	8.82	2.34	2.16
Amniotic Epithelial Cells, donor2	11613-122A2	20.08	8.37	1.67	3.35
Amniotic Epithelial Cells, donor3	11694-123A2	8.22	4.31	2.26	0.62
Anulus Pulposus Cell, donor1	11248-116E6	10.98	6.41	3.32	1.37
Anulus Pulposus Cell, donor2	11463-119B5	10.29	4.41	3.18	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	1.35	1.80	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	2.60	1.30	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	3.59	2.39	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	1.26	1.26	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	3.96	1.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	3.25	0.97	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	4.37	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	4.16	1.19	1.19	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	2.26	2.64	1.13	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	5.08	1.45	0.73	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	6.27	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	2.31	2.14	0.82	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	4.09	0.00	2.73	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	3.92	1.36	0.75	0.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	2.68	1.61	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	3.40	1.13	0.38	1.51
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	4.01	0.80	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	3.90	0.98	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	4.48	1.49	0.66	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	4.80	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	4.46	1.54	0.17	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	4.85	2.43	0.49	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	4.17	1.14	0.76	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	2.42	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	2.85	1.14	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	2.78	1.50	0.43	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	3.61	1.55	0.52	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	1.41	0.94	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	3.86	0.96	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	4.28	2.85	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	3.51	1.17	0.00	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	3.01	1.81	0.30	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	3.56	1.19	1.19	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	2.54	1.53	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	3.82	0.76	0.76	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	2.54	1.91	2.54	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	2.59	0.86	1.29	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	1.91	1.27	0.85	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	2.61	2.03	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	5.67	2.83	0.94	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	2.20	1.19	0.34	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	0.00	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	3.22	0.86	0.21	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	4.81	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	4.37	0.73	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	3.45	0.92	0.46	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5.10	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	3.31	1.02	1.27	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	2.48	1.03	0.41	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	3.37	0.61	0.92	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	5.74	0.00	0.96	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	2.66	0.22	0.22	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	1.53	4.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	1.66	0.55	1.11	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	3.18	1.06	0.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	3.63	1.09	0.73	0.36
Astrocyte - cerebellum, donor1	11500-119F6	10.07	7.12	4.42	4.54
Astrocyte - cerebellum, donor2	11580-120F5	15.75	5.48	3.08	3.94
Astrocyte - cerebellum, donor3	11661-122F5	14.26	9.02	2.52	1.26
Astrocyte - cerebral cortex, donor1	11235-116D2	12.90	13.59	5.23	4.53
Astrocyte - cerebral cortex, donor2	11316-117D2	14.40	14.24	5.50	3.56
Astrocyte - cerebral cortex, donor3	11392-118C6	12.08	11.93	3.13	3.28
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	14.91	12.27	4.47	5.05
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	12.15	10.65	3.38	3.01
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	14.11	11.83	4.78	4.10
Basophils, donor1	12241-129G9	6.28	1.57	1.83	0.26
Basophils, donor2	12242-129H1	11.91	1.80	2.16	0.00
Basophils, donor3	12243-129H2	16.32	1.91	1.76	0.73
Bronchial Epithelial Cell, donor1	11511-119G8	9.92	4.96	1.72	1.94
Bronchial Epithelial Cell, donor2	11591-120G7	16.00	9.14	3.66	1.83
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	10.04	3.77	5.65	3.77
Bronchial Epithelial Cell, donor5	11457-119A8	12.89	5.20	4.57	2.91
Bronchial Epithelial Cell, donor6	11461-119B3	18.19	6.68	6.45	2.07
Bronchial Epithelial Cell, donor7	11769-123I5	13.50	5.94	4.14	1.44
Burkitt's lymphoma cell line:DAUDI	10422-106C8	51.53	17.83	9.48	4.95
Burkitt's lymphoma cell line:RAJI	10476-106I8	15.84	10.48	4.19	3.96
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	57.88	26.86	4.80	6.72
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	0.00	10.34	10.34
CD14+ Monocytes, donor1	11224-116B9	22.54	1.13	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	16.89	1.11	1.30	0.00
CD14+ Monocytes, donor3	11381-118B4	15.59	0.88	0.88	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	34.25	5.09	3.40	4.53
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	28.05	3.79	3.41	3.79
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	27.61	3.62	3.94	1.31
CD14+ monocytes - mock treated, donor1	11863-125A9	16.33	1.01	0.72	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	12.97	0.30	0.91	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	14.21	1.18	1.18	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	12.89	0.67	0.33	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	10.49	0.28	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	10.41	0.00	0.74	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	14.69	0.20	0.98	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	16.91	0.36	1.07	0.89
CD14+ monocytes - treated with BCG, donor3	11880-125C8	18.28	0.44	1.09	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	15.69	1.40	1.40	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	23.76	0.00	1.06	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	19.97	0.00	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	16.96	0.74	0.45	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	9.58	0.40	0.40	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	12.91	0.21	0.62	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	17.62	1.14	1.14	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	17.42	1.36	0.68	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	14.40	1.31	0.87	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	14.26	0.54	0.54	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	23.03	0.87	1.57	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	21.46	0.84	3.37	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	10.84	0.18	0.37	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	12.33	0.70	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	11.41	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	12.90	1.05	0.35	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	14.50	0.00	1.12	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	19.83	0.86	1.72	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	11.88	0.41	2.05	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	10.66	0.00	0.70	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	14.62	0.23	0.93	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	13.08	0.87	0.87	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	18.71	1.62	1.85	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	19.06	3.03	1.52	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	29.28	2.80	3.43	2.34
CD14+CD16- Monocytes, donor2	11799-124C8	26.37	1.40	0.87	1.22
CD14+CD16- Monocytes, donor3	11910-125G2	18.06	0.89	1.78	1.34
CD14-CD16+ Monocytes, donor1	11790-124B8	16.33	2.04	2.04	1.02
CD14-CD16+ Monocytes, donor2	11800-124C9	14.71	1.32	2.63	0.88
CD14-CD16+ Monocytes, donor3	11911-125G3	15.37	2.53	1.89	1.05
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	10.16	12.19	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	21.70	6.78	5.42	4.07
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	27.96	6.21	3.11	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	26.65	10.66	1.07	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	18.76	6.43	6.43	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	14.74	9.13	2.11	2.81
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	15.69	5.49	3.14	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	17.14	10.55	6.59	0.00
CD19+ B Cells, donor1	11544-120B5	16.44	5.75	1.64	0.82
CD19+ B Cells, donor2	11624-122B4	11.61	2.90	2.18	0.73
CD19+ B Cells, donor3	11705-123B4	14.64	5.05	0.00	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	7.68	26.26	7.68	12.12
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	7.99	33.56	3.99	12.78
CD34+ Progenitors, donor1	11545-120B6	22.09	4.02	5.02	2.01
CD34+ Progenitors, donor2	11625-122B5	14.61	2.25	3.37	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	38.70	35.32	9.02	8.27
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	56.37	32.02	12.18	12.40
CD4+ T Cells, donor1	11225-116C1	13.21	6.78	3.93	1.43
CD4+ T Cells, donor2	11306-117C1	12.25	2.45	1.22	1.84
CD4+ T Cells, donor3	11382-118B5	13.42	6.71	2.44	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	11.74	5.10	3.83	4.59
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	17.07	7.19	3.37	3.37
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	17.25	6.90	5.17	1.15
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	19.44	10.90	3.79	6.64
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	27.39	17.56	4.21	9.83
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	13.18	13.18	6.59	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	7.23	5.93	3.32	2.31
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	14.57	7.80	3.22	4.07
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	10.96	6.93	2.90	2.42
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	12.55	7.17	4.93	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	11.88	9.08	5.59	3.14
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	8.36	7.92	2.64	4.40
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	15.18	3.79	2.95	2.53
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	17.45	11.01	4.36	3.53
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	22.05	9.36	5.68	4.68
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	18.76	8.43	3.81	1.90
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	20.37	12.33	5.36	3.75
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	23.31	12.55	1.79	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	13.91	10.01	4.08	3.52
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	14.30	4.98	3.03	3.47
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	10.93	8.20	3.78	3.78
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	11.63	4.04	3.54	4.55
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	16.46	14.73	3.90	3.47
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	5.67	5.23	2.18	2.61
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	23.26	10.89	3.46	4.45
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	21.23	12.00	4.62	4.62
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	20.94	0.00	4.19	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	13.57	9.14	2.77	2.77
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	15.21	6.87	3.44	3.19
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	15.40	9.24	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	15.76	8.59	3.58	3.22
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	12.46	9.69	2.77	1.38
CD8+ T Cells, donor1	11226-116C2	8.18	3.60	0.98	1.96
CD8+ T Cells, donor2	11307-117C2	4.51	1.50	1.50	0.75
CD8+ T Cells, donor3	11383-118B6	11.61	5.05	0.76	1.01
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	6.88	8.26	1.61	2.52
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	6.23	5.51	0.96	0.96
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	6.29	7.11	1.64	1.37
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	5.40	7.21	1.20	1.50
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	6.72	4.56	0.96	0.96
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	5.91	6.59	0.23	1.14
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	6.52	8.26	1.09	1.74
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	5.00	9.74	1.05	3.68
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	6.57	7.74	0.94	1.88
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	6.34	8.15	1.81	3.02
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	7.55	7.84	3.49	1.74
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	6.13	9.06	1.33	1.60
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	6.57	3.06	1.31	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	5.47	4.10	2.28	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	5.97	4.48	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	7.20	7.92	0.72	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	6.91	6.04	0.58	2.30
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	7.07	4.95	1.18	1.18
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	2.85	4.75	0.00	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	4.00	9.53	0.62	2.15
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	5.13	7.05	0.64	1.60
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	8.03	6.88	1.53	1.91
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	7.88	5.91	1.18	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	6.05	6.81	1.51	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	4.82	6.42	2.41	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	6.29	6.29	0.00	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	2.00	10.02	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	14.62	7.31	1.83	1.83
Cardiac Myocyte, donor2	11605-120I3	10.87	6.92	0.99	0.49
Cardiac Myocyte, donor3	11686-122I3	6.31	3.05	0.95	0.32
Chondrocyte - de diff, donor1	11261-116G1	12.48	4.16	3.47	2.08
Chondrocyte - de diff, donor2	11338-117F6	7.82	1.78	1.78	1.07
Chondrocyte - de diff, donor3	11410-118E6	11.61	1.93	2.05	0.34
Chondrocyte - re diff, donor2	11339-117F7	3.58	3.58	2.69	0.90
Chondrocyte - re diff, donor3	11411-118E7	13.75	2.43	0.81	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	13.20	11.82	2.52	3.79
Ciliary Epithelial Cells, donor2	11323-117D9	10.47	6.84	1.92	1.28
Ciliary Epithelial Cells, donor3	11399-118D4	10.97	5.31	1.42	1.68
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	7.15	6.60	1.56	1.56
Corneal Epithelial Cells, donor1	11526-119I5	12.95	8.78	4.39	3.29
Corneal Epithelial Cells, donor2	11606-120I4	20.48	11.38	5.69	1.14
Corneal Epithelial Cells, donor3	11687-122I4	15.08	12.53	7.92	5.88
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	21.63	2.48	2.81	1.32
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	27.44	2.21	2.21	2.52
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	34.51	0.00	3.45	10.35
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	21.81	2.16	2.05	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	11.96	3.76	2.05	1.71
Dendritic Cells - plasmacytoid, donor2	11309-117C4	18.28	1.31	5.22	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	16.45	3.87	1.45	1.45
Endothelial Cells - Aortic, donor0	11207-116A1	10.34	4.34	1.50	2.00
Endothelial Cells - Aortic, donor1	11263-116G3	13.50	2.35	1.17	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	10.46	2.83	1.70	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	7.47	1.97	1.18	0.39
Endothelial Cells - Artery, donor1	11264-116G4	4.07	1.45	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	5.41	1.88	0.94	1.18
Endothelial Cells - Artery, donor3	11413-118E9	9.47	4.73	2.10	2.28
Endothelial Cells - Lymphatic, donor1	11236-116D3	5.54	1.77	1.11	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	4.87	1.22	0.61	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	3.66	1.13	1.13	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	2.67	2.38	1.19	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	2.60	2.08	0.52	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	3.83	2.27	0.85	0.71
Endothelial Cells - Thoracic, donor1	11266-116G6	9.60	2.40	3.60	2.80
Endothelial Cells - Thoracic, donor2	11343-117G2	4.19	2.62	0.52	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	13.67	6.59	2.98	2.11
Endothelial Cells - Umbilical vein, donor2	11324-117E1	14.34	5.87	1.74	1.74
Endothelial Cells - Umbilical vein, donor3	11400-118D5	11.48	6.72	3.05	2.08
Endothelial Cells - Vein, donor1	11267-116G7	4.55	6.83	2.28	0.00
Endothelial Cells - Vein, donor2	11344-117G3	6.99	2.10	0.70	1.40
Endothelial Cells - Vein, donor3	11416-118F3	15.07	3.93	2.51	1.26
Eosinophils, donor1	12244-129H3	30.49	0.00	15.25	0.00
Eosinophils, donor2	12245-129H4	9.90	1.65	0.00	0.00
Eosinophils, donor3	12246-129H5	32.10	3.57	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	8.06	9.77	4.64	1.71
Esophageal Epithelial Cells, donor2	11587-120G3	18.72	4.16	4.16	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27	32.54	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	5.34	0.82	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	1.42	0.11	0.11	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	8.45	3.90	0.76	1.41
Fibroblast - Aortic Adventitial, donor1	11245-116E3	5.09	2.79	0.97	1.09
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	1.09	1.50	0.68	1.09
Fibroblast - Aortic Adventitial, donor2	11326-117E3	3.16	0.95	0.53	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	5.01	3.16	2.37	1.58
Fibroblast - Aortic Adventitial, donor3	11401-118D6	6.64	2.66	1.99	0.66
Fibroblast - Cardiac, donor1	11268-116G8	6.35	2.27	1.81	0.00
Fibroblast - Cardiac, donor2	11345-117G4	4.55	1.52	1.52	0.00
Fibroblast - Cardiac, donor3	11417-118F4	5.05	0.95	0.32	0.47
Fibroblast - Cardiac, donor4	11452-119A3	3.03	1.21	1.21	0.30
Fibroblast - Cardiac, donor5	11456-119A7	9.52	2.54	1.52	0.63
Fibroblast - Cardiac, donor6	11460-119B2	8.79	3.79	2.43	1.06
Fibroblast - Choroid Plexus, donor1	11492-119E7	4.82	2.95	1.61	0.80
Fibroblast - Choroid Plexus, donor2	11572-120E6	8.20	6.90	0.86	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	13.18	4.39	1.46	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	9.46	11.99	3.23	3.92
Fibroblast - Conjunctival, donor3	11692-122I9	12.38	9.84	2.20	1.19
Fibroblast - Dermal, donor1	11269-116G9	3.52	2.11	0.00	0.23
Fibroblast - Dermal, donor2	11346-117G5	4.25	5.19	2.36	3.30
Fibroblast - Dermal, donor3	11418-118F5	4.96	1.69	0.73	0.73
Fibroblast - Dermal, donor4	11450-119A1	9.38	10.85	3.39	3.96
Fibroblast - Dermal, donor5	11454-119A5	12.56	10.99	3.84	3.49
Fibroblast - Dermal, donor6	11458-119A9	11.86	5.20	3.90	4.06
Fibroblast - Gingival, donor1	11237-116D4	8.12	3.96	1.67	1.04
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	7.34	2.88	1.83	0.26
Fibroblast - Gingival, donor2	11318-117D4	12.12	8.57	2.77	3.03
Fibroblast - Gingival, donor3	11394-118C8	11.02	6.09	2.80	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	4.16	3.12	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	5.81	1.94	0.88	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	7.02	4.05	1.71	2.18
Fibroblast - Gingival, donor6 (control)	11922-125H5	4.33	4.19	2.03	1.62
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	1.76	2.12	2.82	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	8.04	4.83	1.75	1.46
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	8.45	2.18	2.05	1.09
Fibroblast - Gingival, donor8 (control)	11926-125H9	6.91	3.84	1.54	1.76
Fibroblast - Gingival, donor9 (control)	11927-125I1	7.04	2.79	0.88	0.44
Fibroblast - Lung, donor1	11270-116H1	2.72	2.72	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	13.43	4.48	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	12.45	9.71	1.27	1.90
Fibroblast - Lymphatic, donor1	11506-119G3	3.33	8.33	1.67	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	4.20	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	3.64	3.36	0.84	0.28
Fibroblast - Mammary, donor1	11540-120B1	8.53	6.50	1.62	3.25
Fibroblast - Mammary, donor2	11620-122A9	3.99	15.98	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	10.28	13.19	4.46	4.27
Fibroblast - Periodontal Ligament, donor2	11319-117D5	11.68	13.04	3.64	4.10
Fibroblast - Periodontal Ligament, donor3	11395-118C9	4.59	2.45	0.31	1.22
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	4.96	1.91	1.91	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	7.02	3.24	1.62	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	5.91	1.97	0.81	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	5.53	3.65	1.55	2.76
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	4.06	5.69	1.63	2.03
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	8.02	4.68	2.00	2.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	10.28	5.54	1.98	1.98
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	6.55	5.16	2.78	2.18
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	4.62	2.31	1.42	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	4.53	2.37	0.99	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	7.52	9.63	4.51	3.01
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	5.72	1.94	1.94	0.76
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	3.80	3.29	2.28	1.52
Fibroblast - skin normal, donor1	11553-120C5	5.58	1.31	0.82	0.66
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	4.61	5.61	2.41	2.21
Fibroblast - skin normal, donor2	11561-120D4	4.12	1.91	1.11	1.11
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	7.56	3.63	3.63	3.32
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	8.53	2.07	1.16	0.58
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	12.48	3.76	1.71	0.85
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	4.60	1.64	0.99	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	4.26	1.81	1.07	1.07
Fibroblast - skin walker warburg, donor1	11554-120C6	4.55	3.54	1.01	0.84
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	2.67	2.04	0.63	0.78
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	9.59	3.49	5.23	2.61
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	3.99	2.08	1.21	1.21
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	4.16	1.30	1.82	1.82
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	3.58	1.79	1.53	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	32.92	25.26	10.72	9.19
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	45.30	28.71	7.66	7.66
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	29.10	12.55	6.85	4.85
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	25.37	34.19	3.86	4.96
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	16.90	15.75	3.42	2.97
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	28.33	14.66	8.12	4.56
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	24.32	29.87	3.70	5.29
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	18.92	8.81	4.24	4.89
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	30.51	14.59	3.98	2.65
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	23.04	17.38	3.67	3.67
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	20.44	12.81	3.82	2.09
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	19.34	11.01	4.30	2.95
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	18.46	6.57	1.73	1.86
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	15.64	6.09	3.18	2.08
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	14.43	3.86	2.24	1.42
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	11.87	10.04	2.74	1.60
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	17.69	7.72	1.37	1.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	14.86	5.90	1.53	2.19
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	18.91	10.64	2.07	2.95
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	15.42	10.33	1.75	1.75
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	14.08	6.48	1.12	1.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	19.76	12.50	2.62	3.23
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	13.06	9.33	2.54	2.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	10.55	6.83	2.39	1.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	9.16	7.49	2.29	0.94
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	5.81	6.32	1.20	1.37
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	13.17	7.52	2.66	1.99
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	11.48	6.99	2.58	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	10.00	5.92	2.65	2.65
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	15.06	10.52	3.30	2.06
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	13.60	9.68	1.84	1.04
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	15.34	6.17	1.33	1.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	19.62	8.82	1.54	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	18.82	7.75	1.35	2.09
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	10.05	8.59	0.97	1.46
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	20.53	11.87	1.92	1.92
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	11.65	7.58	2.46	1.33
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	11.71	5.06	1.27	1.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	11.56	7.91	2.13	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	10.14	6.17	1.05	0.73
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	13.83	9.00	1.76	2.20
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	12.06	8.98	1.68	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	6.67	2.87	1.20	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	9.09	4.28	0.80	1.60
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	6.12	3.98	1.22	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	4.66	3.37	1.55	1.04
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	10.30	4.34	0.81	1.63
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	6.82	3.32	1.11	1.11
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	9.21	5.26	1.54	1.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	4.96	2.98	2.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	5.94	3.30	1.58	1.19
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	8.88	3.83	1.61	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	5.85	1.52	2.29	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	22.49	10.55	3.98	1.99
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	24.34	15.25	3.24	2.77
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	32.12	13.71	4.30	3.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	30.98	26.60	7.20	7.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	35.04	21.76	8.76	7.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	37.36	26.29	8.76	5.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	22.27	12.37	9.90	7.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	25.53	13.15	6.96	4.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	30.48	30.48	11.23	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	36.52	19.13	5.22	8.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	27.34	18.55	4.56	5.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	21.83	15.24	7.00	2.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	26.66	29.99	3.33	10.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	26.85	16.50	5.03	4.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	25.82	17.65	3.60	4.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	28.52	20.97	5.87	3.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	23.54	23.86	3.50	4.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	30.23	21.74	5.77	4.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	56.38	20.88	6.26	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	45.82	33.79	8.59	4.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	26.34	23.09	4.74	4.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	13.55	8.47	1.69	6.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	17.81	14.91	4.97	4.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	15.88	16.80	2.99	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	10.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	21.14	18.07	4.61	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	18.91	14.02	5.87	3.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	40.80	24.08	5.35	3.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	33.13	26.97	4.62	5.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	17.12	16.09	2.40	3.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	27.33	32.30	2.48	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	35.39	23.59	4.25	4.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	41.04	33.80	4.22	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	38.66	18.82	5.60	3.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	33.50	23.93	3.59	2.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	28.12	20.72	4.93	3.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	30.69	27.15	7.08	4.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	48.43	36.17	4.67	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	38.18	16.68	4.83	3.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	19.50	11.02	0.85	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	22.68	16.71	1.19	2.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	15.04	11.65	6.31	1.94
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	2.28	3.42	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	5.82	1.66	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	5.62	6.75	6.75	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	4.76	2.54	0.95	1.27
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	5.85	4.18	1.25	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	19.84	5.92	4.76	3.13
Hep-2 cells mock treated, biol_rep2	11899-125E9	15.19	7.09	4.90	3.21
Hep-2 cells mock treated, biol_rep3	11900-125F1	14.56	4.32	3.64	2.28
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	18.25	6.78	3.83	3.28
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	21.06	7.52	3.87	4.30
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	15.72	5.81	3.88	3.23
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	20.30	5.85	4.23	2.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	14.75	5.49	4.29	2.92
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	19.22	6.09	3.20	2.88
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	9.51	3.92	7.28	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	2.16	3.46	1.73	1.73
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	0.00	2.64	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	5.64	6.00	1.76	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	3.63	0.73	1.45	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	7.34	6.99	1.92	1.57
Hepatocyte, donor1	11523-119I2	1.21	2.42	0.00	0.00
Hepatocyte, donor2	11603-120I1	8.62	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	1.23	3.68	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	19.58	32.63	8.48	17.62
Intestinal epithelial cells (polarized), donor1	11246-116E4	40.55	10.14	6.29	6.82
Iris Pigment Epithelial Cells, donor1	11530-119I9	3.43	2.06	0.55	1.78
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	3.18	15.92	12.74	12.74
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	6.68	0.00	13.35
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	27.08	0.00	54.17
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	19.38	24.92	1.38	9.69
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	15.02	0.00	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	23.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	15.38	17.94	2.56	10.25
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	18.28	9.14	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	16.24	17.87	6.50	11.37
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	16.67	20.01	8.34	5.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	21.78	21.78	3.63	7.26
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	17.21	18.53	7.94	13.23
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	12.20	14.41	3.33	4.43
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	26.19	15.71	10.48
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	16.38	20.79	5.04	9.45
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	7.73	13.92	3.09	7.73
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	14.63	0.00	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	12.92	15.50	6.46	7.75
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	30.59	19.32	14.49	9.66
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	23.90	11.95	35.84
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	14.67	6.52	1.63	7.33
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	11.75	12.17	7.56	9.24
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	28.74	0.00	28.74
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	15.27	11.25	3.21	4.82
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	15.70	8.31	3.69	4.62
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	60.32	0.00	15.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	13.69	10.38	4.72	6.14
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	10.88	11.79	5.44	6.35
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	15.07	26.90	8.61	8.61
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	13.98	16.52	3.81	3.81
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	32.86	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	18.49	15.94	8.93	5.74
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	20.05	25.52	7.29	3.65
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	12.14	12.85	6.43	7.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	16.59	29.86	0.00	6.64
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	41.70	20.85	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	14.20	15.74	4.01	3.70
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	17.56	14.05	10.54	5.27
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	3.14	9.43	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	18.78	13.91	5.56	9.74
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	30.98	17.70	4.43	13.28
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	12.97	12.97	9.73	9.73
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	14.82	13.08	6.10	8.72
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	18.00	29.25	9.00	9.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	20.91	0.00	10.45
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	9.60	18.14	10.67	8.53
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	8.31	9.70	5.54	5.54
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	25.65	25.65	2.85	11.40
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	14.73	9.20	6.44	9.20
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	33.28	18.15	3.03	6.05
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	18.63	0.00	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	17.98	24.32	4.23	6.34
Keratinocyte - epidermal, donor1	11272-116H3	2.86	1.47	0.57	0.57
Keratinocyte - epidermal, donor2	11349-117G8	7.61	8.78	4.10	2.93
Keratinocyte - epidermal, donor3	11421-118F8	10.70	7.19	3.60	3.50
Keratinocyte - oral, donor1	11251-116E9	18.16	13.17	7.95	5.56
Keratocytes, donor1	11527-119I6	8.25	7.91	3.44	1.38
Keratocytes, donor2	11607-120I5	8.20	12.89	1.17	1.17
Keratocytes, donor3	11688-122I5	12.05	3.95	2.77	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	10.99	0.00	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	5.39	2.16	1.08	2.16
Lens Epithelial Cells, donor2	11609-120I7	12.34	9.00	1.96	1.96
Lens Epithelial Cells, donor3	11690-122I7	2.42	1.11	0.81	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	8.30	3.79	1.78	1.42
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	7.54	4.74	1.40	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	5.67	2.68	1.57	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	5.91	3.23	2.69	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	13.55	7.25	3.47	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	7.22	3.13	1.94	0.86
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	7.80	4.10	2.46	2.05
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	11.63	5.06	4.05	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	4.93	2.96	1.97	0.99
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	8.70	1.98	1.58	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	11.05	3.10	1.16	1.94
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	9.07	3.15	1.67	0.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	5.92	4.53	1.05	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	10.50	5.25	2.62	0.95
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	7.14	2.33	2.47	1.10
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	6.16	2.16	1.23	0.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	13.40	4.36	1.56	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	6.95	2.38	1.65	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	7.90	3.62	1.65	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	8.79	5.56	1.17	1.76
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	8.96	3.24	1.24	1.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	7.27	4.36	1.45	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	8.62	3.50	1.35	1.08
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	5.60	2.27	1.21	1.51
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	7.26	5.18	1.04	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	10.05	4.61	1.05	1.68
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	7.82	2.41	1.35	0.60
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	8.25	1.38	0.69	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	8.47	3.57	2.07	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	6.47	3.18	1.17	1.17
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	4.85	3.88	1.94	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	9.26	3.97	0.99	1.65
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	8.30	2.60	0.87	0.62
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	6.66	1.11	0.37	1.48
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	9.64	2.96	1.73	1.24
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	7.29	2.89	0.96	0.55
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	3.86	3.54	0.96	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	7.30	4.26	1.52	1.22
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	7.14	2.52	1.12	0.84
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	7.11	3.56	1.07	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	11.15	1.94	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	7.00	2.18	0.78	0.93
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	8.95	3.94	1.07	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	9.47	2.61	1.63	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	9.18	3.30	0.94	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	6.81	2.60	0.87	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	6.66	4.87	1.54	1.02
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	5.67	1.49	0.90	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	43.05	9.06	11.33	6.80
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	35.29	11.51	3.84	5.37
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	29.69	17.81	5.20	5.20
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	39.77	15.66	6.35	5.92
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	35.17	16.18	6.33	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	28.95	11.21	2.80	2.80
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	32.46	12.88	8.24	3.61
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	32.12	14.27	5.95	10.71
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	32.35	13.80	5.20	5.20
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	32.57	14.25	6.11	4.65
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	30.16	10.35	4.05	3.15
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	29.81	13.41	6.10	5.55
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	41.08	15.41	7.19	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	26.46	14.47	6.00	1.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	17.32	8.00	4.00	6.66
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	43.81	10.19	7.64	6.11
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	30.15	10.67	4.80	4.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	34.20	13.60	4.53	4.91
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	28.22	24.54	6.75	4.91
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	28.54	11.42	4.89	3.26
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	31.86	10.41	3.33	3.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	30.27	12.33	5.61	3.36
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	49.46	5.15	5.15	6.18
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	34.55	11.90	4.94	4.94
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	31.69	11.06	7.77	4.19
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	29.32	10.51	2.77	6.64
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	32.17	12.02	4.24	4.24
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	35.40	9.59	7.74	2.58
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	33.39	10.36	4.61	6.91
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	33.39	13.05	5.37	5.37
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	37.36	17.55	8.49	3.40
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	39.38	20.51	4.92	6.56
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	43.38	13.10	6.78	4.07
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	33.03	20.11	4.31	6.46
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	30.62	8.96	4.48	2.99
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	35.30	10.78	4.46	7.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	29.72	12.49	6.46	3.88
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	46.24	11.99	4.28	6.85
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	33.98	14.33	5.66	6.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	50.68	15.08	6.64	3.62
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	42.66	12.09	4.27	2.84
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	36.78	12.37	6.87	5.16
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	25.76	13.42	1.07	2.68
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	34.34	15.49	6.06	7.41
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	35.56	16.67	4.82	2.59
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	34.89	18.61	9.30	6.98
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	33.85	15.87	4.23	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	36.01	10.80	5.20	4.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	44.34	20.35	4.36	5.09
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	55.96	17.63	6.13	6.13
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	39.46	19.73	6.41	7.89
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	32.93	11.29	4.70	5.65
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	39.22	15.59	4.02	4.02
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	33.35	19.83	6.76	4.06
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	24.10	17.21	1.72	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	35.18	13.36	4.45	5.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	33.24	12.51	6.26	3.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	32.33	11.22	9.24	3.30
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	40.48	11.94	4.67	2.59
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	32.82	12.25	6.13	5.69
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	41.37	12.30	3.91	3.35
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	32.24	11.04	4.42	1.77
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	36.64	13.50	6.56	3.47
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	30.38	10.13	3.04	5.06
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	31.72	10.09	3.84	3.36
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	39.75	7.95	3.58	3.58
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	28.56	10.94	3.65	4.86
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	29.74	15.22	7.61	4.84
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	28.12	10.26	3.42	2.66
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	36.15	18.59	5.16	4.13
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	38.09	10.88	6.65	6.65
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	34.54	17.11	5.39	4.44
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	43.18	12.26	6.93	3.73
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	39.65	10.92	4.60	5.75
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	30.85	15.94	4.11	3.09
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	29.00	19.10	6.37	2.12
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	35.18	5.67	5.11	4.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	37.03	16.22	4.16	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	32.10	13.31	3.92	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	36.33	9.19	4.59	7.10
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	42.28	14.87	5.58	4.65
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	39.47	10.70	3.35	2.68
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	35.29	10.16	5.88	5.88
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	34.35	14.95	4.04	6.47
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	36.71	14.68	7.34	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	27.56	4.45	7.11	6.22
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	34.76	9.12	6.27	3.99
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	37.58	12.27	6.14	3.07
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	33.92	6.57	2.74	2.19
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	24.50	9.35	5.35	4.01
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	27.82	11.18	7.02	3.90
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	35.14	10.61	9.28	6.63
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	49.89	8.31	4.16	4.16
Macrophage - monocyte derived, donor1	11232-116C8	16.41	5.24	3.19	2.96
Macrophage - monocyte derived, donor2	11313-117C8	14.13	2.94	2.57	1.84
Macrophage - monocyte derived, donor3	11389-118C3	27.53	4.59	2.62	3.41
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	3.72	2.12	1.59	1.06
Mallassez-derived cells, donor2	11929-125I3	2.38	2.06	0.16	1.27
Mallassez-derived cells, donor3	11930-125I4	4.45	3.75	1.53	1.81
Mammary Epithelial Cell, donor1	11273-116H4	12.95	8.57	5.98	3.59
Mammary Epithelial Cell, donor2	11350-117G9	8.98	6.95	3.47	2.03
Mammary Epithelial Cell, donor3	11422-118F9	13.72	10.23	4.74	4.49
Mast cell - stimulated, donor1	11487-119E2	4.75	0.00	0.68	1.36
Mast cell, donor1	11563-120D6	7.79	2.81	2.27	0.97
Mast cell, donor2	11565-120D8	4.46	2.38	0.30	0.89
Mast cell, donor3	11566-120D9	4.50	5.18	0.68	1.80
Mast cell, donor4	11567-120E1	4.25	3.01	1.06	1.06
Mast cell, expanded and stimulated, donor5	11940-126A5	3.66	2.33	0.67	0.67
Mast cell, expanded and stimulated, donor8	11942-126A7	4.67	2.33	2.33	0.58
Mast cell, expanded, donor5	11939-126A4	6.19	7.23	0.80	2.98
Mast cell, expanded, donor8	11941-126A6	9.04	6.19	3.01	1.84
Melanocyte - dark, donor1	11502-119F8	3.78	4.38	1.29	0.80
Melanocyte - dark, donor2	11582-120F7	9.00	5.88	1.73	2.42
Melanocyte - dark, donor3	11663-122F7	7.32	6.01	2.90	2.68
Melanocyte - light, donor1	11274-116H5	4.47	1.88	1.18	1.18
Melanocyte - light, donor2	11351-117H1	4.78	3.41	0.68	0.68
Melanocyte - light, donor3	11423-118G1	8.67	2.60	0.00	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	9.16	4.48	1.25	1.87
Melanocyte, donor2 (MC+2)	12739-135I3	9.41	4.03	4.84	1.88
Melanocyte, donor3 (MC+3)	12837-137B2	6.16	3.21	0.54	1.07
Meningeal Cells, donor1	11493-119E8	8.93	6.95	3.85	3.23
Meningeal Cells, donor2	11573-120E7	6.60	4.84	2.64	2.20
Meningeal Cells, donor3	11654-122E7	6.85	4.89	3.02	2.53
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	11.69	9.70	2.00	3.99
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	4.43	1.01	0.40	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	3.94	2.63	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	6.54	5.23	3.92	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	5.74	0.00	2.15	2.15
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	2.96	0.85	0.21	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	4.52	1.01	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	6.37	10.11	3.30	3.96
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	10.96	9.50	4.38	3.65
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	6.14	6.96	2.46	2.25
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	8.03	4.02	2.22	0.69
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	3.35	3.72	1.49	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	8.55	3.55	0.92	0.92
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	6.53	2.08	0.30	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	0.00	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	8.97	13.45	4.48	2.56
Mesenchymal stem cells - adipose, donor0	11217-116B2	5.32	7.09	2.13	2.48
Mesenchymal stem cells - hepatic, donor0	11218-116B3	5.32	2.81	1.88	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	9.43	12.34	3.63	5.08
Mesothelial Cells, donor1	11247-116E5	0.27	1.59	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	0.50	0.50	0.50	0.50
Mesothelial Cells, donor3	11402-118D7	1.95	1.95	0.51	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	14.85	2.70	2.70	4.05
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	19.70	1.48	4.19	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	21.79	2.06	1.77	1.77
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	0.00	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	22.01	2.48	1.24	2.17
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	14.11	3.53	1.66	2.07
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	20.84	0.00	6.95	6.95
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	19.27	2.25	4.00	1.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	19.08	2.33	3.72	1.40
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	19.51	2.03	2.85	0.81
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	15.44	3.17	1.58	3.17
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	0.00	0.00	17.10
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	10.62	1.77	1.77	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	18.24	5.32	2.28	1.90
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	17.11	3.95	0.00	2.63
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	14.64	2.12	1.70	1.06
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	13.81	2.76	0.92	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	11.03	1.49	1.79	1.49
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	10.06	0.00	1.68	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	13.30	1.76	2.01	2.26
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	13.78	1.90	0.48	1.66
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	11.06	0.55	1.11	1.11
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	12.20	1.61	1.15	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	11.99	2.31	2.31	1.47
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	10.80	1.63	0.61	1.22
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	12.01	2.15	1.50	1.50
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	7.34	2.00	1.11	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	9.64	1.75	1.31	0.88
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	7.60	1.01	0.51	1.52
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	6.63	1.66	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	10.06	1.63	1.09	1.09
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	11.18	2.35	1.18	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	6.54	0.00	1.09	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	9.13	0.48	2.88	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	14.81	0.80	2.80	1.60
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	2.74	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	10.01	1.50	2.00	2.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	26.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	12.23	0.00	2.04	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	9.20	2.19	2.19	1.75
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	4.41	0.00	1.10	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	3.84	1.28	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	6.20	1.98	1.24	0.99
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	6.26	0.70	3.48	1.39
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	15.47	4.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	9.23	3.76	1.37	1.03
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	9.63	0.88	0.88	2.63
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	9.94	2.49	1.07	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	10.38	4.21	1.96	1.68
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	13.30	1.25	2.08	2.08
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	11.07	1.17	3.50	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	8.75	2.11	0.90	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	12.10	1.67	2.09	3.76
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	14.78	1.85	2.77	1.85
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	9.11	0.57	1.71	2.85
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	8.71	1.52	1.93	2.21
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	8.03	3.89	1.55	1.55
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	9.87	0.86	3.86	3.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	12.70	0.64	0.64	1.91
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	9.61	2.40	1.60	1.87
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	14.07	2.69	3.89	3.59
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	7.35	1.55	1.55	1.41
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	11.15	4.14	2.55	3.19
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	15.48	4.42	4.42	2.21
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	10.62	2.28	1.14	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	9.94	3.98	2.56	2.84
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	13.76	2.46	5.16	2.46
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	4.56	1.30	1.30	1.30
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	7.06	2.94	2.06	1.76
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	10.96	0.86	2.31	1.44
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	8.66	3.30	1.65	1.24
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	7.44	3.87	4.17	1.49
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	26.37	3.77	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	23.17	1.78	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	17.74	2.96	0.66	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	30.51	3.16	3.16	4.21
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	24.32	5.14	2.97	3.36
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	27.94	0.93	0.93	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	21.78	2.63	0.75	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	20.77	1.60	2.66	2.13
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	10.52	2.15	1.58	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	16.94	0.74	1.47	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	17.59	2.93	1.47	1.83
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	18.67	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	3.21	1.07	1.07	1.07
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	27.05	3.86	3.86	7.73
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	16.16	0.00	5.05	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	10.54	0.42	1.26	1.69
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.91	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.05	0.00	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	6.04	0.00	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	19.57	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	9.50	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	4.31	1.08	0.00	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	6.79	3.14	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	4.67	2.67	0.67	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	2.50	1.67	0.83	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	5.13	3.04	1.52	1.52
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	9.58	3.19	3.19	3.19
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	6.12	3.40	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	3.68	3.68	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	6.28	1.67	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	3.25	0.93	0.46	1.16
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	3.51	2.16	1.35	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	4.20	1.68	0.84	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	2.48	2.98	0.00	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	2.98	1.89	0.54	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	5.89	1.36	0.45	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	4.74	2.45	0.16	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	4.37	1.28	1.09	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	5.30	0.53	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	5.40	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	2.30	1.97	0.33	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	3.90	0.98	0.49	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	3.70	0.53	0.53	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	4.22	0.70	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	5.06	1.84	0.92	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	5.14	1.29	0.32	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	3.45	0.34	0.00	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	0.00	0.00	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	4.68	1.78	0.45	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	5.93	0.42	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	2.37	2.61	0.24	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	7.73	2.15	1.72	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	9.00	1.00	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	6.31	0.45	1.35	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	5.56	1.59	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	4.64	1.86	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	3.41	1.14	0.76	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	4.89	0.33	1.30	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	10.46	4.36	0.87	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	7.24	0.90	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.94	0.88	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	7.98	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	5.46	0.00	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	8.42	0.38	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	12.10	5.14	0.30	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	4.86	1.33	0.44	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	2.71	2.03	1.36	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	10.36	1.83	0.61	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	4.41	0.63	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	9.68	0.91	1.21	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	5.54	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	1.13	0.00	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	3.35	2.11	1.12	1.61
Myoblast, donor2	11322-117D8	6.52	1.92	1.34	1.34
Myoblast, donor3	11398-118D3	3.87	2.69	2.02	2.02
NK T cell leukemia cell line:KHYG-1	10777-110G3	24.08	17.22	2.92	2.63
Natural Killer Cells, donor1	11230-116C6	7.07	2.15	3.08	0.62
Natural Killer Cells, donor2	11311-117C6	6.03	1.81	1.81	0.90
Natural Killer Cells, donor3	11387-118C1	9.20	4.05	1.66	0.55
Neural stem cells, donor1	11275-116H6	3.27	2.54	0.73	0.73
Neural stem cells, donor2	11352-117H2	1.93	1.93	0.00	1.93
Neurons, donor1	11494-119E9	5.69	4.55	2.28	1.14
Neurons, donor2	11574-120E8	5.94	4.84	1.76	2.42
Neurons, donor3	11655-122E8	5.76	1.64	0.82	0.82
Neutrophils, donor1	11233-116C9	16.70	1.86	5.57	1.86
Neutrophils, donor2	11314-117C9	5.80	0.00	2.90	0.00
Neutrophils, donor3	11390-118C4	50.70	3.05	11.00	4.89
Nucleus Pulposus Cell, donor1	11252-116F1	11.04	5.58	2.02	0.59
Nucleus Pulposus Cell, donor2	11409-118E5	16.28	10.42	2.93	1.30
Nucleus Pulposus Cell, donor3	11462-119B4	10.23	3.01	2.21	0.40
Olfactory epithelial cells, donor1	11933-125I7	6.74	1.24	1.10	0.14
Olfactory epithelial cells, donor2	11934-125I8	6.08	1.59	0.72	0.72
Olfactory epithelial cells, donor3	11935-125I9	9.87	1.59	1.02	0.91
Olfactory epithelial cells, donor4	11936-126A1	10.81	3.51	2.14	0.97
Oligodendrocyte - precursors, donor1	11496-119F2	7.82	2.41	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	11.49	3.83	0.85	0.21
Osteoblast - differentiated, donor2	11353-117H3	16.00	1.14	2.29	0.00
Osteoblast - differentiated, donor3	11425-118G3	12.41	5.59	2.48	0.62
Osteoblast, donor1	11277-116H8	13.09	7.23	3.13	0.78
Osteoblast, donor2	11354-117H4	4.92	3.51	1.40	0.70
Osteoblast, donor3	11426-118G4	8.53	6.40	1.42	1.42
Pancreatic stromal cells, donor1	11249-116E7	5.05	3.20	1.26	0.84
Pericytes, donor1	11491-119E6	6.56	4.78	1.78	0.78
Pericytes, donor2	11571-120E5	7.92	4.75	2.72	0.91
Pericytes, donor3	11652-122E5	12.00	2.44	1.02	1.02
Perineurial Cells, donor1	11499-119F5	7.57	4.41	2.15	1.02
Perineurial Cells, donor2	11579-120F4	8.37	4.42	2.67	1.84
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	13.39	2.23	1.91	1.59
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	20.57	2.45	1.96	1.96
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	15.01	3.88	0.78	0.78
Placental Epithelial Cells, donor1	11278-116H9	5.98	3.59	1.91	0.48
Placental Epithelial Cells, donor2	11355-117H5	6.65	8.87	4.44	0.00
Placental Epithelial Cells, donor3	11427-118G5	16.10	11.58	9.23	1.96
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	4.11	1.90	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	4.88	1.50	0.56	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	1.31	1.57	1.31	1.17
Preadipocyte - breast, donor2	11328-117E5	3.60	1.58	0.23	0.23
Preadipocyte - omental, donor1	11468-119C1	1.92	1.17	0.75	0.32
Preadipocyte - omental, donor2	11329-117E6	3.06	0.44	1.31	1.31
Preadipocyte - omental, donor3	11403-118D8	4.58	1.43	0.43	0.14
Preadipocyte - perirenal, donor1	11469-119C2	1.97	0.98	1.97	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	3.07	2.46	0.61	1.23
Preadipocyte - subcutaneous, donor2	11356-117H6	5.67	5.84	1.59	3.19
Preadipocyte - subcutaneous, donor3	11428-118G6	3.58	2.38	1.02	1.36
Preadipocyte - visceral, donor1	11280-116I2	4.66	3.54	1.58	2.70
Preadipocyte - visceral, donor2	11357-117H7	2.76	4.14	1.38	0.92
Preadipocyte - visceral, donor3	11429-118G7	5.02	4.70	2.09	1.57
Prostate Epithelial Cells (polarized), donor1	11253-116F2	31.38	5.43	4.98	1.51
Prostate Epithelial Cells, donor2	11331-117E8	1.22	0.81	0.54	0.41
Prostate Epithelial Cells, donor3	11404-118D9	9.74	1.59	1.10	0.24
Prostate Stromal Cells, donor1	11254-116F3	4.21	3.08	1.71	1.82
Prostate Stromal Cells, donor2	11332-117E9	4.48	4.84	1.43	1.08
Prostate Stromal Cells, donor3	11405-118E1	3.13	1.77	1.15	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	10.22	7.30	4.74	1.82
Renal Cortical Epithelial Cells, donor2	11596-120H3	5.61	5.27	1.87	1.73
Renal Epithelial Cells, donor1	11517-119H5	7.61	7.61	2.03	1.52
Renal Epithelial Cells, donor2	11597-120H4	10.67	11.38	2.13	3.56
Renal Epithelial Cells, donor3	11678-122H4	8.05	6.25	2.54	1.48
Renal Glomerular Endothelial Cells, donor1	11514-119H2	9.53	4.09	4.09	2.72
Renal Glomerular Endothelial Cells, donor2	11594-120H1	12.13	3.64	3.37	2.70
Renal Glomerular Endothelial Cells, donor3	11675-122H1	10.21	5.55	3.55	2.66
Renal Glomerular Endothelial Cells, donor4	11783-124B1	4.66	2.66	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	6.60	7.04	3.08	1.76
Renal Mesangial Cells, donor2	11598-120H5	10.66	16.30	1.88	3.13
Renal Mesangial Cells, donor3	11679-122H5	8.60	7.77	2.50	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	9.93	8.59	3.76	2.68
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	12.65	8.01	2.95	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	9.84	9.64	2.70	3.28
Retinal Pigment Epithelial Cells, donor0	11215-116A9	8.82	8.56	1.56	4.15
Retinal Pigment Epithelial Cells, donor1	11528-119I7	7.67	7.96	2.84	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	8.23	7.20	3.09	4.12
Retinal Pigment Epithelial Cells, donor3	11689-122I6	8.78	2.76	2.26	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	9.89	6.55	3.47	1.34
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	26.80	6.25	7.15	7.15
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	11.01	3.85	3.30	3.85
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	13.92	4.06	2.32	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	9.10	2.60	3.90	2.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	13.11	4.27	3.97	2.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	16.95	6.02	6.92	3.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	16.50	4.71	4.59	3.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	13.64	5.24	3.15	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	17.80	5.55	3.47	1.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	12.32	3.15	2.46	2.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	15.43	5.90	2.42	2.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	17.74	6.09	4.66	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	12.62	4.73	2.87	2.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	13.84	5.37	2.90	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	16.37	4.43	4.87	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	12.04	3.44	2.68	2.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	15.65	4.47	3.07	2.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	11.09	6.76	3.57	2.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	10.75	3.58	2.26	1.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	11.78	3.80	2.34	2.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	14.89	5.92	4.01	2.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	12.49	2.88	3.63	2.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	13.17	3.64	2.80	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	11.28	5.98	3.42	2.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	14.40	4.01	4.92	3.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	10.55	4.54	3.92	3.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	17.06	5.10	4.30	2.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	13.21	3.54	2.83	2.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	13.29	3.97	3.37	4.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	16.14	6.08	2.34	3.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	11.40	3.32	3.32	2.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	13.72	3.54	2.43	1.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	14.41	4.39	3.76	2.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	10.77	3.77	5.11	3.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	13.79	3.75	3.24	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	15.42	3.86	3.86	2.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	11.86	4.99	2.92	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	15.36	4.66	2.88	2.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	17.89	4.76	4.43	3.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	16.36	2.73	3.41	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	18.49	6.07	4.44	2.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	16.53	3.73	2.13	2.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	18.94	4.98	4.15	2.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	21.19	4.29	2.86	2.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	20.56	5.24	3.02	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	17.42	4.43	4.90	3.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	27.60	8.38	3.14	2.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	27.50	7.25	5.44	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	18.97	4.28	5.14	3.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	32.46	11.35	5.97	3.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	35.90	12.17	2.43	3.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	18.69	4.22	4.82	2.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	27.14	7.01	5.88	3.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	34.75	11.98	8.09	5.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	20.90	6.26	5.55	3.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	33.94	10.46	8.54	2.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	32.45	13.82	2.40	3.61
Schwann Cells, donor1	11498-119F4	15.42	11.85	4.14	3.95
Schwann Cells, donor2	11578-120F3	13.61	10.21	6.80	3.40
Schwann Cells, donor3	11659-122F3	7.23	7.45	1.75	1.97
Sebocyte, donor1	11220-116B5	3.83	1.10	1.10	1.64
Sebocyte, donor2	11301-117B5	5.51	1.84	1.84	1.38
Sebocyte, donor3	11378-118B1	6.39	4.33	1.44	0.82
Sertoli Cells, donor1	11255-116F4	8.28	9.94	0.00	1.66
Sertoli Cells, donor2	11333-117F1	5.65	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	11.96	4.66	1.67	1.23
Skeletal Muscle Cells, donor2	11358-117H8	3.61	1.45	0.72	0.72
Skeletal Muscle Cells, donor3	11430-118G8	21.74	2.51	3.34	1.67
Skeletal Muscle Cells, donor4	11451-119A2	12.57	6.60	5.66	3.14
Skeletal Muscle Cells, donor5	11455-119A6	10.41	9.66	4.46	3.86
Skeletal Muscle Cells, donor6	11459-119B1	9.39	7.70	4.77	3.54
Skeletal Muscle Satellite Cells, donor1	11240-116D7	10.71	14.24	4.41	1.89
Skeletal Muscle Satellite Cells, donor2	11321-117D7	11.56	11.27	2.71	2.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	7.94	8.73	2.38	2.28
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	4.55	2.53	0.84	0.84
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	20.27	11.58	3.62	3.62
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	8.67	1.79	1.79	0.96
Skin - palm, donor1	10286-104F7	16.12	10.74	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	1.73	1.30	0.58	0.86
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	7.36	4.91	0.00	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	5.58	3.89	1.43	1.43
Small Airway Epithelial Cells, donor1	11256-116F5	4.59	1.11	0.83	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	6.47	1.55	0.70	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	12.90	10.15	5.92	4.86
Small Airway Epithelial Cells, donor3	11406-118E2	8.17	1.72	1.20	0.45
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	3.09	1.23	0.62	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	0.44	0.44	0.00	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	7.64	2.94	1.18	1.76
Smooth Muscle Cells - Aortic, donor1	11283-116I5	4.64	0.88	0.44	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	3.94	1.58	0.39	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	10.82	1.55	0.77	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	12.01	4.00	5.00	3.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	2.66	0.67	0.53	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	4.88	2.44	0.89	0.89
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	8.07	2.69	0.90	1.41
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	6.51	5.86	2.93	1.63
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	7.09	2.36	0.59	1.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	5.55	1.99	0.71	0.85
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	4.55	4.88	1.30	0.81
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	9.44	4.87	0.91	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	9.85	7.32	1.26	2.02
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	6.68	1.91	0.48	1.91
Smooth Muscle Cells - Colonic, donor1	11239-116D6	3.39	4.13	0.88	0.88
Smooth Muscle Cells - Colonic, donor2	11320-117D6	4.74	3.66	2.15	1.29
Smooth Muscle Cells - Colonic, donor3	11396-118D1	6.82	4.51	1.47	1.57
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	4.02	2.17	0.93	0.93
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	6.47	0.00	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	5.38	1.79	1.49	1.20
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	6.49	9.22	2.73	2.05
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	10.84	9.03	3.85	1.10
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	1.51	0.60	0.10	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	4.78	1.59	1.37	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	6.64	3.02	3.02	2.42
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	4.77	7.42	3.71	2.91
Smooth Muscle Cells - Prostate, donor1	11257-116F6	2.26	2.40	2.13	0.93
Smooth Muscle Cells - Prostate, donor2	11335-117F3	4.26	1.75	0.50	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	5.83	1.52	0.51	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	5.73	4.07	1.36	1.81
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	4.50	3.00	2.25	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	3.88	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	6.98	5.58	0.47	2.33
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	6.06	0.00	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	4.70	0.31	0.63	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	2.36	2.06	1.18	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	7.83	6.66	3.25	3.42
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	8.88	5.61	1.40	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	5.32	1.58	1.15	0.86
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	6.88	4.59	1.02	2.04
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	12.22	5.08	2.82	1.88
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	5.87	5.31	3.07	2.10
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	4.19	2.85	0.84	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	4.76	4.29	0.00	1.43
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	3.67	0.49	1.22	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	1.55	0.00	0.22	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	3.22	4.97	2.34	2.34
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	6.03	1.17	0.58	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	1.59	1.06	0.26	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	1.86	2.23	0.74	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	1.80	1.08	0.36	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	2.27	1.14	0.28	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	6.70	5.51	0.79	2.36
Smooth muscle cells - airway, control, donor1	11966-126D4	3.30	1.02	0.25	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	6.79	3.19	0.80	1.60
Smooth muscle cells - airway, control, donor3	11968-126D6	10.87	2.93	0.84	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	6.42	0.92	1.83	0.46
Synoviocyte, donor1	11291-117A4	5.55	0.84	1.18	0.84
Synoviocyte, donor2	11368-117I9	8.72	2.68	1.34	1.01
Synoviocyte, donor3	11440-118H9	8.27	2.23	0.89	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	7.15	11.43	4.29	4.65
Trabecular Meshwork Cells, donor2	11612-122A1	0.00	3.96	3.96	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	9.03	7.64	3.47	4.40
Tracheal Epithelial Cells, donor1	11292-117A5	13.62	7.67	3.94	3.58
Tracheal Epithelial Cells, donor2	11369-118A1	15.08	3.87	5.80	1.93
Tracheal Epithelial Cells, donor3	11441-118I1	13.74	4.01	7.44	2.29
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	10.09	7.01	1.85	1.35
Urethra, donor2	10319-105A4	21.58	5.40	3.60	1.80
Urothelial Cells, donor1	11520-119H8	3.45	1.59	1.33	0.80
Urothelial Cells, donor2	11600-120H7	5.61	6.01	0.80	0.80
Urothelial Cells, donor3	11681-122H7	5.27	2.52	2.29	1.38
Urothelial cells, donor0	11216-116B1	6.69	2.45	2.90	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	24.02	2.67	5.34	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	28.59	1.43	4.29	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	23.27	3.42	4.79	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	18.94	5.85	3.44	2.41
Whole blood (ribopure), donor090325, donation2	12177-128I8	28.47	4.65	2.91	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	29.15	4.16	8.33	5.21
Whole blood (ribopure), donor090612, donation2	12183-129A5	25.70	1.84	5.51	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	16.43	2.74	2.74	1.83
Wilms' tumor cell line:G-401	10809-111A8	10.36	9.75	2.22	2.59
Wilms' tumor cell line:HFWT	10597-108E3	33.44	3.52	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	19.55	6.98	3.35	3.63
achilles tendon, donor2	10292-104G4	16.53	8.27	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	23.46	9.69	6.37	5.61
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	20.90	19.50	6.50	7.66
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	20.30	17.57	6.05	5.82
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	11.97	19.32	7.35	7.35
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	11.81	19.11	4.50	5.90
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	51.39	16.50	8.04	7.61
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	24.50	5.44	5.44	2.18
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	54.64	13.66	6.61	5.29
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	29.40	10.62	4.08	4.49
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	53.20	8.54	6.21	8.54
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	10.12	6.62	2.21	2.58
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	39.01	19.50	7.80	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	16.27	13.94	2.56	3.72
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	22.78	19.16	5.95	5.44
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	38.58	14.61	5.84	9.06
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	24.63	7.90	4.18	2.79
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	19.33	9.05	4.11	3.70
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	57.40	20.26	8.29	10.74
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	32.43	9.39	4.69	5.97
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	25.78	6.07	2.73	4.25
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	32.50	11.55	5.30	4.57
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	21.83	6.46	4.45	2.90
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	10.34	10.67	5.00	6.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	9.29	7.43	3.72	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	19.21	12.05	4.90	5.27
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	22.24	10.03	4.36	5.23
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	7.50	3.75	3.75	0.00
adenocarcinoma cell line:IM95m	10796-110I4	27.55	13.42	5.42	4.71
adipose tissue, adult, pool1	10010-101C1	8.38	3.41	0.62	0.47
adipose, donor1	10184-103D4	17.01	17.01	4.69	1.76
adipose, donor2	10185-103D5	14.19	19.46	3.24	2.43
adipose, donor3	10186-103D6	10.35	8.71	2.18	2.45
adipose, donor4	10187-103D7	19.94	9.53	2.60	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	5.68	6.00	1.58	1.10
adrenal gland, adult, pool1	10081-102A9	0.00	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	23.08	9.34	5.87	3.47
alveolar cell carcinoma cell line:SW 1573	10708-109H6	15.01	8.58	2.14	1.79
amniotic membrane cells, donor1	12235-129G3	14.37	4.64	2.78	2.55
amniotic membrane cells, donor2	12236-129G4	30.77	8.79	6.09	4.40
amniotic membrane cells, donor3	12237-129G5	22.39	6.78	6.48	2.65
amygdala - adult, donor10196	10167-103B5	0.00	2.37	0.00	0.00
amygdala, adult, donor10252	10151-102I7	6.29	4.46	1.62	1.62
amygdala, newborn, donor10223	10360-105E9	2.58	3.55	0.00	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	22.28	6.49	2.04	0.64
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	29.78	10.81	11.69	6.18
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	20.71	10.69	3.67	1.67
aorta, adult, pool1	10052-101G7	12.16	4.31	1.77	1.18
appendix, adult	10189-103D9	20.57	12.03	1.16	4.66
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	9.63	6.53	2.75	0.69
artery, adult	10190-103E1	2.72	5.43	1.36	1.36
astrocytoma cell line:TM-31	10425-106D2	11.73	6.23	4.06	1.74
b cell line:RPMI1788	10427-106D4	15.32	13.98	4.46	3.27
basal cell carcinoma cell line:TE 354.T	10702-109G9	4.72	2.50	1.11	1.11
bile duct carcinoma cell line:HuCCT1	10432-106D9	9.53	2.18	1.89	1.89
bile duct carcinoma cell line:TFK-1	10496-107C1	5.52	2.34	1.17	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	73.26	13.98	8.95	3.91
bladder, adult, pool1	10011-101C2	10.21	4.24	1.30	1.09
blood, adult, pool1	10053-101G8	22.15	4.43	4.43	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	10.28	4.28	2.57	0.00
bone marrow, adult	10192-103E3	14.17	1.35	2.02	0.67
brain, adult, donor1	10084-102B3	2.05	4.10	0.00	1.03
brain, adult, pool1	10012-101C3	2.78	3.79	0.78	1.00
brain, fetal, pool1	10085-102B4	5.34	8.01	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	49.89	5.29	4.96	1.65
breast carcinoma cell line:MDA-MB-453	10419-106C5	18.22	7.11	4.87	4.24
breast, adult, donor1	10080-102A8	8.21	0.63	1.89	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	6.73	6.48	1.52	1.91
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	15.46	4.64	2.78	2.78
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	26.01	14.73	4.37	3.68
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	11.38	6.29	4.84	3.63
carcinoid cell line:NCI-H1770	10703-109H1	22.57	30.09	6.58	7.52
carcinoid cell line:NCI-H727	10735-110B6	20.78	8.09	2.63	1.97
carcinoid cell line:SK-PN-DW	10719-109I8	6.02	12.36	2.54	2.54
carcinosarcoma cell line:JHUCS-1	10642-109A3	22.36	14.64	5.32	3.73
caudate nucleus - adult, donor10196	10177-103C6	3.45	11.51	2.30	1.15
caudate nucleus, adult, donor10252	10164-103B2	5.35	9.54	1.34	0.84
caudate nucleus, adult, donor10258	10379-105H1	7.64	16.05	0.00	3.06
caudate nucleus, newborn, donor10223	10354-105E3	4.03	4.03	0.73	0.73
cerebellum - adult, donor10196	10173-103C2	0.00	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	4.48	7.26	1.71	0.64
cerebellum, adult, pool1	10083-102B2	3.10	6.55	2.76	1.03
cerebellum, newborn, donor10223	10357-105E6	4.98	3.32	0.00	1.66
cerebral meninges, adult	10188-103D8	5.55	2.77	1.51	0.25
cerebrospinal fluid, donor2	10294-104G6	9.50	6.58	1.46	0.00
cervical cancer cell line:D98-AH2	10552-107I3	30.48	3.88	6.04	1.58
cervical cancer cell line:ME-180	10553-107I4	21.54	11.43	9.45	7.29
cervix, adult, pool1	10013-101C4	11.76	8.50	3.15	1.78
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	2.93	1.11	0.42	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	18.29	3.92	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	34.18	13.67	5.72	5.47
choriocarcinoma cell line:SCH	10785-110H2	51.38	12.94	5.42	2.59
choriocarcinoma cell line:T3M-3	10618-108G6	24.67	8.54	2.37	1.66
chorionic membrane cells, donor1	12238-129G6	10.54	5.13	2.85	1.42
chorionic membrane cells, donor2	12239-129G7	5.27	1.69	1.69	0.60
chorionic membrane cells, donor3	12240-129G8	17.03	3.30	2.75	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	15.15	24.24	8.08	8.08
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	13.06	4.99	4.03	1.92
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	9.29	3.38	1.06	1.27
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	13.35	11.81	1.28	3.08
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	9.43	11.13	4.60	5.08
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	10.99	9.57	3.46	2.65
chronic myelogenous leukemia cell line:K562	10454-106G4	10.89	17.08	4.71	8.83
chronic myelogenous leukemia cell line:KU812	10409-106B4	11.21	9.12	5.47	7.30
clear cell carcinoma cell line:JHOC-5	10638-108I8	11.43	14.17	2.97	4.57
clear cell carcinoma cell line:TEN	10636-108I6	26.03	7.63	3.12	2.78
colon carcinoma cell line:CACO-2	10513-107D9	22.15	8.05	4.21	5.86
colon carcinoma cell line:COLO-320	10420-106C6	34.21	37.63	14.44	15.20
colon, adult, donor1	10082-102B1	21.42	4.76	4.76	7.14
colon, adult, pool1	10014-101C5	15.86	5.88	3.17	3.29
colon, fetal, donor1	10070-101I7	22.87	11.12	4.94	1.24
common myeloid progenitor CMP, donor1	12130-128D6	137.51	36.67	18.33	22.92
common myeloid progenitor CMP, donor2	12134-128E1	75.11	25.04	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	10.20	9.35	2.97	1.70
cord blood derived cell line:COBL-a 24h infection	10453-106G3	10.11	8.60	2.41	2.87
cord blood derived cell line:COBL-a untreated	10449-106F8	10.86	9.87	3.81	3.24
corpus callosum, adult, pool1	10042-101F6	6.74	9.29	1.55	1.88
cruciate ligament, donor2	10295-104G7	17.83	5.67	1.62	1.62
diaphragm, fetal, donor1	10069-101I6	7.22	1.61	0.00	0.00
diencephalon, adult	10193-103E4	5.28	5.76	0.96	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	21.81	21.12	2.76	2.76
ductal cell carcinoma cell line:KLM-1	10438-106E6	19.49	6.15	4.87	1.80
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	12.28	6.74	3.13	2.41
ductus deferens, adult	10196-103E7	13.46	5.98	2.99	1.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	11.52	8.64	4.32	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	9.56	2.94	2.94	1.47
dura mater, adult, donor1	10041-101F5	11.07	2.48	1.07	0.50
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	15.32	10.66	6.44	5.77
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	13.04	9.60	5.02	4.44
embryonic pancreas cell line:1B2C6	10604-108F1	11.10	2.47	0.62	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	13.32	5.75	1.51	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	10.81	1.85	2.16	0.31
embryonic pancreas cell line:2C6	10603-108E9	13.13	1.31	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	10.73	1.68	2.68	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	15.04	11.60	3.08	1.63
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	5.63	2.09	1.93	0.96
epidermoid carcinoma cell line:A431	10426-106D3	22.34	9.00	7.89	5.89
epidermoid carcinoma cell line:Ca Ski	10431-106D8	9.24	2.97	2.64	1.76
epididymis, adult	10197-103E8	10.05	6.91	2.30	3.35
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	7.63	6.56	1.60	1.95
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	3.54	2.75	3.54	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	24.38	5.11	2.88	1.70
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	26.77	4.63	1.97	2.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	23.19	4.82	2.91	1.79
esophagus, adult, pool1	10015-101C6	11.36	6.80	3.19	2.87
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	16.53	10.27	2.13	1.63
eye - muscle inferior rectus, donor1	10272-104E2	2.41	2.41	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	4.21	6.31	0.00	4.21
eye - muscle medial, donor2	10299-104H2	7.44	2.98	0.00	2.98
eye - muscle superior, donor2	10297-104G9	8.03	3.44	1.15	2.29
eye - vitreous humor, donor1	10268-104D7	10.20	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	10.93	4.83	1.27	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	12.57	6.03	2.44	2.56
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	7.36	5.94	2.85	1.66
frontal lobe, adult, pool1	10040-101F4	1.97	3.66	0.28	0.94
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	27.02	5.70	7.51	5.10
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	7.68	4.85	2.10	1.74
gall bladder, adult	10198-103E9	14.49	8.93	5.07	3.38
gamma delta positive T cells, donor1	11937-126A2	9.66	5.91	6.44	2.68
gamma delta positive T cells, donor2	11938-126A3	10.83	8.59	1.12	3.36
gastric adenocarcinoma cell line:MKN1	10614-108G2	6.34	2.53	0.42	1.27
gastric adenocarcinoma cell line:MKN45	10612-108F9	14.51	6.00	1.93	1.55
gastric cancer cell line:AZ521	10549-107H9	16.72	12.62	6.72	4.26
gastric cancer cell line:GSS	10560-108A2	1.83	13.73	1.83	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	18.73	11.19	4.80	2.28
giant cell carcinoma cell line:LU65	10487-107B1	8.49	1.03	1.03	0.69
giant cell carcinoma cell line:Lu99B	10433-106E1	7.00	5.74	1.54	1.12
glassy cell carcinoma cell line:HOKUG	10688-109F4	12.97	7.73	4.74	1.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	5.07	2.74	0.74	1.37
glioblastoma cell line:A172, tech_rep2	10444-106F3	3.79	2.95	1.26	1.26
glioblastoma cell line:T98G	10485-107A8	5.74	5.63	0.88	2.10
glioma cell line:GI-1	10413-106B8	10.25	2.93	0.29	0.29
globus pallidus - adult, donor10196	10175-103C4	6.56	4.37	0.73	0.73
globus pallidus, adult, donor10252	10161-103A8	12.94	9.03	1.95	1.71
globus pallidus, adult, donor10258	10367-105F7	8.22	6.85	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	4.26	6.40	1.07	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	161.51	56.28	26.92	29.37
granulocyte macrophage progenitor, donor2	12135-128E2	76.50	21.86	32.79	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	109.76	31.36	5.23	10.45
granulosa cell tumor cell line:KGN	10624-108H3	6.08	2.56	0.64	0.64
hIPS +CCl2, biol_rep1	14383-156B9	11.02	15.61	1.38	3.21
hIPS +CCl2, biol_rep2	14384-156C1	8.69	7.32	2.74	2.29
hIPS +CCl2, biol_rep3	14385-156C2	12.24	14.81	1.29	3.86
hIPS, biol_rep1	14380-156B6	20.12	5.75	0.00	2.87
hIPS, biol_rep2	14381-156B7	13.72	12.35	1.37	3.43
hIPS, biol_rep3	14382-156B8	3.31	8.83	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	8.33	7.18	0.86	1.44
heart - mitral valve, adult	10205-103F7	7.47	5.08	1.49	0.60
heart - pulmonic valve, adult	10206-103F8	7.32	4.71	1.31	1.31
heart - tricuspid valve, adult	10207-103F9	7.49	5.00	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	9.59	6.33	1.22	2.45
heart, adult, diseased, donor1	10051-101G6	7.24	8.52	0.85	0.43
heart, adult, pool1	10016-101C7	9.43	5.06	3.68	0.92
heart, fetal, pool1	10046-101G1	10.37	7.39	1.85	1.13
hepatic mesenchymal tumor cell line:LI90	10778-110G4	4.63	2.78	0.00	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	65.40	7.14	5.95	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	32.26	17.24	6.41	6.74
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	32.77	18.33	6.31	6.31
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	35.97	20.82	7.58	7.17
hepatoma cell line:Li-7	10484-107A7	11.23	1.89	2.45	0.78
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	15.88	9.35	3.72	3.52
hippocampus - adult, donor10196	10169-103B7	1.89	2.84	0.00	1.89
hippocampus, adult, donor10252	10153-102I9	9.59	5.92	1.63	0.41
hippocampus, adult, donor10258	10374-105G5	3.49	3.98	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	4.23	1.06	0.35	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	31.74	25.02	4.88	5.49
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	30.63	16.30	6.87	4.12
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	37.83	15.74	8.89	3.05
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	32.70	34.40	5.07	8.46
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	23.50	26.85	4.13	4.65
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	29.61	38.34	4.18	6.07
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	16.64	19.85	2.63	3.21
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	18.31	22.19	3.23	3.45
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	14.60	18.35	2.92	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	11.84	12.55	2.60	4.97
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	12.70	12.05	3.54	4.02
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	14.14	12.12	4.04	4.04
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	24.41	9.86	5.32	3.29
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	23.58	9.33	4.91	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	30.55	27.06	10.47	6.98
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	20.43	28.25	3.05	2.86
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	14.83	24.86	2.18	2.18
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	23.99	25.99	0.50	3.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	10.74	14.69	1.32	3.01
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	9.55	15.92	1.82	2.73
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	13.78	16.60	1.88	4.07
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	9.47	7.68	0.98	2.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	5.23	9.87	1.45	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	9.27	8.07	1.79	2.69
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	28.45	15.33	5.36	4.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	23.39	17.40	3.99	3.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	30.22	20.42	6.12	5.72
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	15.49	16.90	3.17	4.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	17.10	18.69	3.48	5.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	19.67	24.81	3.63	3.93
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	12.41	12.41	1.55	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	9.30	9.96	3.32	5.31
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	16.67	14.88	3.33	3.08
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	8.69	8.69	3.58	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	18.93	9.09	3.03	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	12.43	11.09	2.02	3.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	26.57	15.21	6.52	4.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	24.96	15.60	7.13	4.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	31.71	21.95	5.85	6.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	20.78	21.70	4.58	4.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	26.03	52.05	19.52	19.52
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	25.15	26.81	4.96	6.29
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	14.23	17.51	2.19	6.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	16.65	18.82	2.53	3.62
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	13.52	15.66	2.49	3.56
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	19.09	9.55	1.19	3.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	8.94	10.02	2.17	2.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	10.51	10.51	4.58	3.23
immature langerhans cells, donor1	11904-125F5	33.90	0.00	0.97	0.24
immature langerhans cells, donor2	11905-125F6	57.03	3.96	2.38	1.58
insula, adult, pool1	10039-101F3	2.74	5.20	0.57	1.04
keratoacanthoma cell line:HKA-1	10791-110H8	24.71	12.03	5.53	4.55
kidney, adult, pool1	10017-101C8	8.01	3.10	1.90	1.70
kidney, fetal, pool1	10045-101F9	11.39	6.58	2.12	2.26
large cell lung carcinoma cell line:IA-LM	10509-107D5	8.24	1.28	0.14	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	37.88	5.94	2.07	1.38
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	55.05	13.21	10.28	3.85
left atrium, adult, donor1	10079-102A7	6.54	5.45	0.54	1.09
left ventricle, adult, donor1	10078-102A6	10.11	4.05	0.51	1.52
leiomyoblastoma cell line:G-402	10721-110A1	6.57	3.01	2.19	0.27
leiomyoma cell line:10964C	10569-108B2	1.44	2.51	0.72	1.08
leiomyoma cell line:15242A	10570-108B3	1.09	0.00	0.54	0.54
leiomyoma cell line:15425	10571-108B4	2.67	3.40	0.24	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	12.55	4.18	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	6.61	1.65	1.30	1.77
liposarcoma cell line:KMLS-1	10782-110G8	5.47	2.97	0.94	1.09
liposarcoma cell line:SW 872	10726-110A6	15.11	6.34	1.71	2.31
liver, adult, pool1	10018-101C9	5.35	3.24	1.94	0.97
liver, fetal, pool1	10086-102B5	4.70	1.88	0.94	0.94
locus coeruleus - adult, donor10196	10182-103D2	5.25	4.08	1.17	0.44
locus coeruleus, adult, donor10252	10165-103B3	9.04	5.35	1.48	1.66
locus coeruleus, adult, donor10258	10375-105G6	5.92	6.21	0.85	0.28
locus coeruleus, newborn, donor10223	10362-105F2	5.47	2.52	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	15.50	5.54	3.04	0.55
lung adenocarcinoma cell line:PC-14	10408-106B3	7.58	0.69	1.38	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	18.98	3.43	3.16	1.85
lung, adult, pool1	10019-101D1	19.02	4.73	3.31	2.24
lung, fetal, donor1	10068-101I5	8.56	2.85	2.85	0.57
lung, right lower lobe, adult, donor1	10075-102A3	13.75	5.96	0.46	1.83
lymph node, adult, donor1	10077-102A5	16.57	5.21	1.42	0.47
lymphangiectasia cell line:DS-1	10727-110A7	25.42	5.26	4.38	2.41
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	12.07	8.60	3.32	4.08
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	2.55	0.85	4.25	0.00
mature adipocyte, donor1	12231-129F8	10.21	14.21	5.33	4.88
mature adipocyte, donor2	12232-129F9	11.83	6.23	2.08	3.11
mature adipocyte, donor3	12233-129G1	7.82	5.45	2.84	1.66
mature adipocyte, donor4	12234-129G2	12.63	6.84	1.84	1.32
maxillary sinus tumor cell line:HSQ-89	10414-106B9	3.81	2.62	0.71	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	0.00	2.26	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	4.60	5.70	1.29	0.92
medial frontal gyrus, adult, donor10258	10368-105F8	2.22	5.08	1.27	1.91
medial frontal gyrus, newborn, donor10223	10352-105E1	2.13	1.71	0.43	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	2.36	4.22	0.34	1.01
medial temporal gyrus, adult, donor10252	10156-103A3	7.85	3.40	0.85	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	0.00	1.93	1.93	3.85
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	28.71	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	2.87	2.51	0.00	0.36
medulla oblongata - adult, donor10196	10174-103C3	5.84	3.24	0.65	1.30
medulla oblongata, adult, donor10252	10155-103A2	8.36	6.04	1.70	1.08
medulla oblongata, adult, pool1	10038-101F2	4.41	3.84	0.98	1.31
medulla oblongata, newborn, donor10223	10361-105F1	4.86	4.17	0.69	1.04
medulloblastoma cell line:D283 Med	10838-111E1	14.83	24.36	2.88	4.21
medulloblastoma cell line:ONS-76	10759-110E3	10.76	5.26	2.45	2.32
melanoma cell line:COLO 679	10514-107E1	6.47	2.44	1.44	0.29
melanoma cell line:G-361	10465-106H6	4.34	3.26	0.54	0.27
meningioma cell line:HKBMM	10691-109F7	14.29	6.15	2.35	1.81
merkel cell carcinoma cell line:MKL-1	10843-111E6	9.69	20.27	1.76	7.05
merkel cell carcinoma cell line:MS-1	10844-111E7	5.96	12.96	6.22	4.15
mesenchymal precursor cell - adipose, donor1	11747-123G1	4.30	2.30	1.99	0.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	5.64	4.36	0.55	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	3.73	1.24	0.83	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	6.88	1.40	1.12	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	5.97	1.35	0.39	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	4.16	1.39	1.39	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	4.12	0.00	0.51	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	5.87	0.58	0.35	0.46
mesenchymal precursor cell - cardiac, donor3	11754-123G8	5.04	1.46	1.19	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	6.21	3.78	2.03	1.89
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	4.41	0.85	1.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	1.98	1.65	0.66	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	4.70	1.66	0.97	0.97
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	4.89	4.19	1.40	1.40
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	6.12	1.02	1.22	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	2.16	1.80	0.36	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	4.86	1.55	0.62	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	1.14	0.91	0.23	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	5.87	3.78	3.36	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	2.99	1.79	0.30	0.75
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	4.03	1.05	0.88	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	2.58	0.74	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	3.43	0.86	0.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	8.42	6.32	3.79	4.21
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	7.76	3.20	2.28	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	5.12	2.56	1.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	4.71	1.57	1.05	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	7.70	2.77	0.62	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	4.00	2.82	0.24	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	6.09	2.71	0.68	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	4.72	2.75	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	8.34	0.93	0.46	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	6.63	2.02	0.87	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	6.02	2.90	0.45	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	5.77	2.16	0.96	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	3.67	2.93	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	6.04	1.68	0.67	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	9.01	2.87	1.64	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	3.87	3.01	1.29	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	8.20	8.20	2.73	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	5.16	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	9.74	2.27	1.30	1.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	13.09	1.45	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	9.60	3.73	3.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	7.36	3.27	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	6.22	3.89	0.78	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	8.39	0.00	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	3.97	3.97	0.00	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	9.49	3.56	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	12.18	1.22	2.44	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	9.50	2.53	0.63	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	6.90	4.48	2.41	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	4.30	6.45	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	7.98	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	0.00	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	14.67	2.04	0.41	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	5.56	3.18	1.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	13.56	1.18	1.77	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	7.48	3.12	2.81	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	20.05	2.67	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	14.19	5.91	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	15.41	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	7.57	2.07	1.38	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	7.42	2.97	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	7.85	2.24	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	8.90	2.54	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	6.45	4.03	0.40	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	2.18	2.18	4.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	6.34	1.27	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	3.64	3.03	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	7.41	3.29	1.65	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	9.33	2.98	1.79	1.19
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	7.46	2.60	1.62	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	10.19	2.04	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	3.87	1.55	2.32	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	2.83	3.78	2.60	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	3.24	3.24	2.32	1.62
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	8.55	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	7.40	2.67	2.77	1.23
mesothelioma cell line:Mero-25	10850-111F4	7.72	5.45	1.82	3.18
mesothelioma cell line:Mero-41	10851-111F5	4.16	5.38	0.49	0.73
mesothelioma cell line:Mero-48a	10852-111F6	7.53	1.77	1.33	1.99
mesothelioma cell line:Mero-82	10853-111F7	6.57	3.94	1.05	1.31
mesothelioma cell line:Mero-83	10854-111F8	9.70	2.38	0.51	1.87
mesothelioma cell line:Mero-84	10855-111F9	6.82	7.58	1.77	2.02
mesothelioma cell line:Mero-95	10856-111G1	9.11	3.31	1.86	1.04
mesothelioma cell line:NCI-H2052	10847-111F1	3.48	4.97	1.49	1.99
mesothelioma cell line:NCI-H226	10846-111E9	5.97	2.53	1.63	1.45
mesothelioma cell line:NCI-H2452	10848-111F2	6.15	3.76	1.54	0.51
mesothelioma cell line:NCI-H28	10845-111E8	12.98	2.29	1.02	1.27
mesothelioma cell line:No36	10857-111G2	17.94	5.87	1.63	0.98
mesothelioma cell line:ONE58	10858-111G3	4.06	3.25	0.54	0.81
migratory langerhans cells, donor1	11901-125F2	3.07	2.30	0.77	0.38
migratory langerhans cells, donor2	11902-125F3	4.15	1.22	0.49	0.24
migratory langerhans cells, donor3	11903-125F4	10.77	2.51	0.54	0.72
mixed mullerian tumor cell line:HTMMT	10689-109F5	17.63	3.26	2.94	1.31
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	14.84	5.51	3.60	2.76
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	29.03	2.99	5.07	0.92
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	8.56	6.47	1.52	2.47
myelodysplastic syndrome cell line:SKM-1	10772-110F7	57.47	10.90	7.95	3.14
myeloma cell line:PCM6	10474-106I6	15.62	5.53	3.76	1.19
myxofibrosarcoma cell line:MFH-ino	10600-108E6	29.93	7.10	6.09	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	14.12	5.49	3.33	2.16
nasal epithelial cells, donor1, tech_rep1	12226-129F3	15.49	3.68	3.12	0.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	15.81	2.94	3.90	1.03
nasal epithelial cells, donor2	12227-129F4	12.14	4.97	2.76	2.76
neuroblastoma cell line:CHP-134	10508-107D4	17.48	12.19	3.91	2.53
neuroblastoma cell line:NB-1	10539-107G8	17.96	10.10	4.49	3.55
neuroblastoma cell line:NBsusSR	10607-108F4	9.49	3.80	1.27	0.63
neuroblastoma cell line:NH-12	10555-107I6	18.82	14.35	4.29	1.49
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	34.87	22.30	9.25	2.14
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	12.83	13.30	4.12	2.06
neuroectodermal tumor cell line:TASK1	10774-110F9	15.50	14.49	5.64	2.01
neuroepithelioma cell line:SK-N-MC	10728-110A8	9.54	12.72	6.99	2.54
neurofibroma cell line:Hs 53.T	10729-110A9	7.19	1.60	0.27	0.27
neutrophil PMN, donor1	12133-128D9	14.87	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	37.88	0.00	9.47	18.94
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	20.13	34.50	7.44	8.12
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	19.21	10.41	5.60	2.40
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	7.05	4.17	0.32	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	8.15	2.36	1.05	1.58
nucleus accumbens, adult, pool1	10037-101F1	3.47	5.81	0.84	1.31
occipital cortex - adult, donor10196	10172-103C1	0.00	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	11.00	8.86	1.88	2.68
occipital cortex, newborn, donor10223	10355-105E4	1.09	2.91	0.00	0.73
occipital lobe, adult, donor1	10076-102A4	2.10	3.67	0.26	1.84
occipital lobe, fetal, donor1	10073-102A1	4.72	8.58	3.43	1.72
occipital pole, adult, pool1	10036-101E9	2.13	4.89	0.63	1.02
olfactory region, adult	10195-103E6	3.82	4.97	0.38	0.76
optic nerve, donor1	10277-104E7	14.01	12.01	2.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	9.91	2.28	2.28	1.03
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	13.60	16.76	3.98	5.22
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	15.24	1.69	2.20	1.52
oral squamous cell carcinoma cell line:SAS	10544-107H4	27.84	4.97	3.23	1.96
osteoclastoma cell line:Hs 706.T	10704-109H2	13.82	3.53	1.47	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	14.02	2.80	2.80	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	9.97	2.33	2.12	0.64
ovary, adult, pool1	10020-101D2	14.41	5.33	1.66	1.05
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	16.13	4.77	1.83	1.28
pancreas, adult, donor1	10049-101G4	15.05	5.64	1.88	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	30.19	4.47	3.07	2.52
papillary adenocarcinoma cell line:8505C	10437-106E5	6.30	1.87	0.00	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	19.87	6.13	3.97	1.66
paracentral gyrus, adult, pool1	10035-101E8	2.11	3.20	0.73	0.92
parietal cortex, adult, donor10258	10373-105G4	5.87	5.87	0.00	0.73
parietal lobe - adult, donor10196	10171-103B9	0.94	4.70	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	4.85	5.70	0.29	1.14
parietal lobe, adult, pool1	10034-101E7	2.47	4.14	0.88	0.62
parietal lobe, fetal, donor1	10072-101I9	6.79	4.85	3.88	0.00
parietal lobe, newborn, donor10223	10356-105E5	3.36	1.87	0.00	0.00
parotid gland, adult	10199-103F1	22.82	4.32	0.00	1.23
penis, adult	10200-103F2	9.13	5.37	1.07	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	5.21	7.44	1.86	0.74
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	23.17	5.54	3.50	2.77
pineal gland - adult, donor10196	10179-103C8	1.94	1.29	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	3.55	5.33	0.59	0.59
pineal gland, adult, donor10258	10377-105G8	2.51	3.14	0.00	1.25
pituitary gland - adult, donor10196	10180-103C9	4.05	2.02	3.04	1.01
pituitary gland, adult, donor10252	10162-103A9	6.78	5.21	2.61	1.04
pituitary gland, adult, donor10258	10378-105G9	9.36	11.92	2.55	0.85
placenta, adult, pool1	10021-101D3	5.38	4.52	0.86	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	8.21	10.46	2.12	2.78
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	7.32	3.58	1.40	0.78
pons, adult, pool1	10033-101E6	2.67	2.32	0.43	1.12
postcentral gyrus, adult, pool1	10032-101E5	2.62	4.27	0.61	1.22
promyelocytes/myelocytes PMC, donor1	12132-128D8	171.49	62.74	29.28	23.01
promyelocytes/myelocytes PMC, donor2	12136-128E3	88.13	11.02	5.51	11.02
promyelocytes/myelocytes PMC, donor3	12140-128E7	105.62	11.74	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	10.49	6.41	3.50	3.50
prostate cancer cell line:PC-3	10439-106E7	16.15	5.99	4.72	1.45
prostate, adult, pool1	10022-101D4	10.79	5.08	1.81	2.09
putamen, adult, donor10196	10176-103C5	5.19	7.79	1.42	1.89
putamen, adult, donor10252	10152-102I8	7.84	5.88	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	6.56	9.84	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	4.35	7.73	0.97	0.48
putamen, newborn, donor10223	10365-105F5	0.75	6.00	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	46.84	3.49	5.82	0.58
rectum, fetal, donor1	10067-101I4	27.82	11.13	1.39	6.95
renal cell carcinoma cell line:OS-RC-2	10411-106B6	3.39	4.66	1.48	1.27
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	6.63	10.77	3.31	1.24
retina, adult, pool1	10030-101E3	9.05	5.07	2.48	1.09
retinoblastoma cell line:Y79	10475-106I7	28.32	25.20	4.42	8.31
rhabdomyosarcoma cell line:KYM-1	10787-110H4	7.25	11.19	2.83	3.81
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	9.28	5.91	3.94	2.81
sacrococcigeal teratoma cell line:HTST	10695-109G2	9.09	1.52	0.76	1.52
salivary acinar cells, donor1	11771-123I7	8.42	0.49	1.29	0.49
salivary acinar cells, donor2	11772-123I8	16.38	4.96	2.07	0.83
salivary acinar cells, donor3	11773-123I9	23.83	3.31	4.63	0.66
salivary gland, adult, pool1	10093-102C3	17.16	3.43	1.14	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	8.68	3.54	1.35	0.67
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	7.99	3.88	1.29	1.06
seminal vesicle, adult	10201-103F3	8.99	8.99	1.59	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	6.80	3.89	2.19	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	2.52	1.51	0.50	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	3.01	3.01	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	20.01	4.03	2.01	1.21
signet ring carcinoma cell line:Kato III	10436-106E4	6.08	3.43	1.22	0.88
signet ring carcinoma cell line:NUGC-4	10483-107A6	10.58	4.52	2.32	2.32
skeletal muscle - soleus muscle, donor1	10282-104F3	2.13	2.13	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	8.16	4.44	1.44	0.48
skeletal muscle, fetal, donor1	10066-101I3	17.09	1.01	3.02	0.00
skin, adult, donor1	10074-102A2	40.71	6.79	0.00	13.57
skin, fetal, donor1	10065-101I2	17.04	4.42	0.63	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	7.67	7.00	2.67	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	12.29	12.29	5.99	3.78
small cell lung carcinoma cell line:DMS 144	10841-111E4	8.10	10.22	1.35	2.31
small cell lung carcinoma cell line:LK-2	10541-107H1	4.45	2.64	0.99	1.15
small cell lung carcinoma cell line:NCI-H82	10842-111E5	13.19	23.64	1.77	2.41
small cell lung carcinoma cell line:WA-hT	10562-108A4	15.04	20.27	3.70	3.49
small intestine, adult, pool1	10024-101D6	15.77	8.00	4.30	4.54
small intestine, fetal, donor1	10064-101I1	14.50	6.63	2.95	1.72
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	4.62	5.13	1.54	0.00
smooth muscle, adult, pool1	10048-101G3	9.30	7.24	1.81	1.81
somatostatinoma cell line:QGP-1	10781-110G7	8.04	1.34	1.34	0.27
spinal cord - adult, donor10196	10181-103D1	9.41	4.82	0.69	0.69
spinal cord, adult, donor10252	10159-103A6	14.59	7.89	1.97	1.18
spinal cord, adult, donor10258	10369-105F9	3.46	10.38	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	11.59	4.88	0.61	0.61
spinal cord, newborn, donor10223	10359-105E8	6.89	4.13	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	3.73	3.29	1.19	0.60
spleen, adult, pool1	10025-101D7	10.79	3.41	2.97	1.65
spleen, fetal, pool1	10044-101F8	12.08	4.29	2.46	1.43
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	9.73	4.97	1.55	1.66
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	43.10	22.22	9.11	5.32
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	11.53	6.64	3.84	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	34.79	4.69	3.52	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	13.39	7.77	3.71	1.35
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	3.81	10.59	4.24	1.69
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	4.65	3.81	1.69	0.42
stomach, fetal, donor1	10062-101H8	21.36	4.27	5.34	3.20
submaxillary gland, adult	10202-103F4	21.65	2.28	1.71	2.85
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	9.76	7.27	2.28	2.70
substantia nigra, adult, donor10258	10371-105G2	3.10	7.24	0.00	1.55
substantia nigra, newborn, donor10223	10358-105E7	12.01	3.53	2.12	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	5.04	7.11	2.98	3.67
temporal lobe, adult, pool1	10031-101E4	2.63	3.90	0.76	0.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	6.41	9.26	0.71	3.56
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	4.40	3.96	1.76	1.32
tenocyte, donor1	11763-123H8	7.33	4.89	0.70	1.40
tenocyte, donor2	11765-123I1	9.92	8.77	1.14	2.67
tenocyte, donor3	11768-123I4	4.08	4.08	1.85	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	9.35	9.52	1.70	1.87
teratocarcinoma cell line:NCR-G1	10798-110I6	56.88	23.89	8.48	5.55
teratocarcinoma cell line:PA-1	10807-111A6	28.83	13.33	6.35	2.32
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	16.50	7.11	2.92	2.29
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	10.21	6.05	1.13	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	15.49	2.07	0.87	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	7.17	14.33	5.21	1.95
testis, adult, pool1	10026-101D8	5.26	9.23	1.50	1.50
testis, adult, pool2	10096-102C6	2.71	11.73	0.45	4.96
thalamus - adult, donor10196	10168-103B6	3.31	3.31	2.21	0.00
thalamus, adult, donor10252	10154-103A1	12.19	8.44	2.50	0.94
thalamus, adult, donor10258, tech_rep1	10370-105G1	4.62	12.32	1.54	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	6.26	4.61	0.16	1.15
thalamus, newborn, donor10223	10366-105F6	4.60	0.58	0.58	0.58
throat, adult	10209-103G2	9.24	5.99	2.00	0.75
throat, fetal, donor1	10061-101H7	14.63	6.70	2.13	1.83
thymic carcinoma cell line:Ty-82	10803-111A2	14.51	34.58	8.35	10.73
thymus, adult, pool1	10027-101D9	17.50	12.33	3.78	4.47
thymus, fetal, pool1	10043-101F7	11.22	7.27	3.53	3.53
thyroid carcinoma cell line:KHM-5M	10776-110G2	9.04	2.13	2.26	1.33
thyroid carcinoma cell line:TCO-1	10783-110G9	25.70	7.12	1.68	1.40
thyroid, adult, pool1	10028-101E1	15.21	8.02	2.24	1.49
thyroid, fetal, donor1	10060-101H6	8.96	3.95	0.53	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	12.32	9.24	0.00	0.00
tongue, adult	10203-103F5	7.91	5.12	1.40	1.16
tongue, fetal, donor1	10059-101H5	3.94	5.12	1.58	0.79
tonsil, adult, pool1	10047-101G2	13.22	7.41	3.81	2.10
trachea, adult, pool1	10029-101E2	11.62	5.07	1.06	1.31
trachea, fetal, donor1	10058-101H4	11.93	6.16	1.92	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	7.09	3.19	1.06	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	8.71	3.65	2.33	1.82
transitional-cell carcinoma cell line:JMSU1	10492-107B6	32.90	5.33	3.92	2.51
tridermal teratoma cell line:HGRT	10694-109G1	26.64	7.61	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	10.92	3.30	0.68	0.00
umbilical cord, fetal, donor1	10057-101H3	10.43	2.09	2.09	0.00
uterus, adult, pool1	10100-102D1	9.73	8.02	2.73	1.54
uterus, fetal, donor1	10055-101H1	22.01	14.85	2.56	3.58
vagina, adult	10204-103F6	9.69	2.58	0.00	0.65
vein, adult	10191-103E2	10.96	6.58	2.41	1.75
xeroderma pigentosum b cell line:XPL 17	10563-108A5	9.88	4.27	3.20	0.27